Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
Werte in diesem Artikel
In the latest trading session, Teladoc (TDOC) closed at $7.87, marking a +2.61% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.13% for the day. Elsewhere, the Dow saw a downswing of 0.27%, while the tech-heavy Nasdaq depreciated by 0.07%. Coming into today, shares of the telehealth services provider had gained 2.4% in the past month. In that same time, the Medical sector gained 0.73%, while the S&P 500 gained 2.71%. Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of -$0.24, marking a 26.32% fall compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $625.56 million, down 2.33% from the year-ago period. For the full year, the Zacks Consensus Estimates project earnings of -$1.17 per share and a revenue of $2.52 billion, demonstrating changes of +80.07% and -1.82%, respectively, from the preceding year. Investors might also notice recent changes to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Currently, Teladoc is carrying a Zacks Rank of #3 (Hold). The Medical Services industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 99, finds itself in the top 41% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. 3 Stocks Poised to Lead the AI Software RaceThe software market is expected to witness a remarkable growth trajectory worldwide. Advancements in AI, increased demand for cybersecurity, and the rapid expansion of automation and robotics is offering investors an opportunity to unlock significant growth right now.Which software stocks will soar? Which will fizzle out? Find out in our urgent special report, Software is Eating the World. It examines where the software industry stands now and reveals three favorite software stocks to ownAccess the report free today >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Teladoc und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Teladoc
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teladoc
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Teladoc Inc
Analysen zu Teladoc Inc
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
05.06.2018 | Teladoc Buy | Canaccord Adams | |
15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
28.02.2018 | Teladoc Buy | Chardan Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
05.06.2018 | Teladoc Buy | Canaccord Adams | |
28.02.2018 | Teladoc Buy | Chardan Capital Markets | |
08.12.2017 | Teladoc Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
18.09.2017 | Teladoc Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teladoc Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen